HCV protease inhibitors and uses thereof
This invention relates to: (a) compounds of formula I and salts thereof that, inter alia, are useful as hepatitis C virus (HCV) inhibitors; (b) intermediates useful for the preparation of such compounds and salts; (c) pharmaceutical compositions comprising such compounds and salts; and (d) methods of use of such compounds, salts, and compositions.
AbbVie Inc.
C C C C C A C
C07D C07D C07D C07D C07K A61P C07D
inventional inventional inventional inventional inventional inventional inventional
Larry L. Ming C. Dachun Brian E. Keith F. Allan C. Jason P. Todd D. Curt S. Teresa A. David D. Christopher E. Hui-Ju John K. Daniel P. Todd W.
Klein Yeung Liu Green McDaniel Krueger Shanley Bosse Cooper Rosenberg Anderson Motter Chen Pratt Larson Rockway